A new study is drawing attention after comparing some of the most popular weight loss medications currently available.
Researchers found that one drug stood out for delivering significantly stronger results than others in its class.
The medication, known as tirzepatide, showed greater weight loss compared to semaglutide — another widely used option.
In the study, participants taking tirzepatide lost around 20% of their body weight over time, while those on semaglutide lost about 14%.
That difference may not sound huge at first, but experts say it can translate to meaningful changes in overall health outcomes.
Tirzepatide works slightly differently than traditional GLP-1 drugs by targeting multiple pathways involved in appetite and metabolism.
Because of this, it may lead to stronger appetite suppression and improved fat metabolism compared to other medications.
Still, experts caution that results can vary depending on the individual, and these medications should always be used under medical supervision.
While the findings reinforce previous research, they also highlight how quickly treatments in this space are evolving.
